6533b833fe1ef96bd129bfaf

RESEARCH PRODUCT

?(1,3)Fucosyltransferase expression in E-selectin-mediated binding of gastrointestinal tumor cells

H. KaulenK. GottClemens A. SchmittK H Meyer Zum BüschenfeldeB M WittigWolfgang DippoldE. BartnikR. Thees

subject

Cancer Researchmedicine.medical_specialtyFucosyltransferasebiologyCell adhesion moleculemedicine.drug_classTransfectionMonoclonal antibodyMolecular biologycarbohydrates (lipids)FucosyltransferasesEndocrinologyOncologyCell cultureInternal medicineE-selectinmedicinebiology.proteinOncofetal antigen

description

E-selectin recognizes the oncofetal antigen sialyl-Lewis X, which is highly expressed in adenocarcinoma. Five α(1,3)fucosyltransferases (FT) have been cloned that confer cell-surface expression of sialyl-Lewis X on transfected cells. We show here that 12/18 gastrointestinal-tumor cell lines bind specifically to immobilized E-selectin and that in sialyl-Lewis-X-positive cells binding is inhibited with a monoclonal antibody against sialyl-Lewis X. Using RT-PCR, we determined the expression of the α(1,3)fucosyltransferases III, IV, V, VI and VII in gastrointestinal tumor cells. Transcripts of FT IV and FT VII are abundantly expressed in all tested cells. Therefore no single fucosyltransferase could be correlated with the expression of sialyl-Lewis X and the ability of the tumor cells to bind to E-selectin. The data suggest that in gastrointestinal-tumor cells sialyl-Lewis X is necessary but not sufficient for E-selectin binding. © 1996 Wiley-Liss, Inc.

https://doi.org/10.1002/(sici)1097-0215(19960703)67:1<80::aid-ijc14>3.0.co;2-g